Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1742-4690

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants ; volume:18 ; number:1 ; day:28 ; month:6 ; year:2021 ; pages:1-11 ; date:12.2021
Retrovirology ; 18, Heft 1 (28.6.2021), 1-11, 12.2021

Creator: Moore, Catherine M.
Grandits, Melanie
Grünwald-Gruber, Clemens
Altmann, Friedrich
Kotouckova, Maria
Teh, Audrey Y.-H
Ma, Julian K.-C

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12977-021-00560-6

URN: urn:nbn:de:101:1-2021101021220233183456

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:25 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Moore, Catherine M.
Grandits, Melanie
Grünwald-Gruber, Clemens
Altmann, Friedrich
Kotouckova, Maria
Teh, Audrey Y.-H
Ma, Julian K.-C
SpringerLink (Online service)

Other Objects (12)

Human semen contains exosomes with potent anti-HIV-1 activity

Potent Anti‐HIV Activity of Alkyl‐Modified Di PP ro‐Nucleotides

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies

Hochschulschrift

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

Hochschulschrift

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

A plant-biotechnology approach for producing highly potent anti-HIV antibodies for antiretroviral therapy consideration

HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Discovery of an L‐like Configuration for 3’‐Fluoro‐5’‐norcarbonucleoside Phosphonates as Potent Anti‐HIV Agents

Transgenic Mice, Carrying an Expressed Anti-HIV Ribozyme in Their Genome, Show No Sign of Phenotypic Alterations

Hochschulschrift

Model-based anti-HIV therapy

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

Human semen contains exosomes with potent anti-HIV-1 activity

Potent Anti‐HIV Activity of Alkyl‐Modified Di PP ro‐Nucleotides

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies

Hochschulschrift

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

Hochschulschrift

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

A plant-biotechnology approach for producing highly potent anti-HIV antibodies for antiretroviral therapy consideration

HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Discovery of an L‐like Configuration for 3’‐Fluoro‐5’‐norcarbonucleoside Phosphonates as Potent Anti‐HIV Agents

Transgenic Mice, Carrying an Expressed Anti-HIV Ribozyme in Their Genome, Show No Sign of Phenotypic Alterations

Hochschulschrift

Model-based anti-HIV therapy

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

Human semen contains exosomes with potent anti-HIV-1 activity

Potent Anti‐HIV Activity of Alkyl‐Modified Di PP ro‐Nucleotides

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies

Hochschulschrift

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

Hochschulschrift

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

A plant-biotechnology approach for producing highly potent anti-HIV antibodies for antiretroviral therapy consideration

HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Discovery of an L‐like Configuration for 3’‐Fluoro‐5’‐norcarbonucleoside Phosphonates as Potent Anti‐HIV Agents

Transgenic Mice, Carrying an Expressed Anti-HIV Ribozyme in Their Genome, Show No Sign of Phenotypic Alterations

Hochschulschrift

Model-based anti-HIV therapy

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Human semen contains exosomes with potent anti-HIV-1 activity

Potent Anti‐HIV Activity of Alkyl‐Modified Di PP ro‐Nucleotides

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

A plant-biotechnology approach for producing highly potent anti-HIV antibodies for antiretroviral therapy consideration

HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Discovery of an L‐like Configuration for 3’‐Fluoro‐5’‐norcarbonucleoside Phosphonates as Potent Anti‐HIV Agents

Transgenic Mice, Carrying an Expressed Anti-HIV Ribozyme in Their Genome, Show No Sign of Phenotypic Alterations

Model-based anti-HIV therapy

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

Human semen contains exosomes with potent anti-HIV-1 activity

Potent Anti‐HIV Activity of Alkyl‐Modified Di PP ro‐Nucleotides

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

A plant-biotechnology approach for producing highly potent anti-HIV antibodies for antiretroviral therapy consideration

HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Discovery of an L‐like Configuration for 3’‐Fluoro‐5’‐norcarbonucleoside Phosphonates as Potent Anti‐HIV Agents

Transgenic Mice, Carrying an Expressed Anti-HIV Ribozyme in Their Genome, Show No Sign of Phenotypic Alterations

Model-based anti-HIV therapy

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

Human semen contains exosomes with potent anti-HIV-1 activity

Potent Anti‐HIV Activity of Alkyl‐Modified Di PP ro‐Nucleotides

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

Characterization of human anti-HIV-1 Env-specific monoclonal antibodies in vitro and in vivo

A plant-biotechnology approach for producing highly potent anti-HIV antibodies for antiretroviral therapy consideration

HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Discovery of an L‐like Configuration for 3’‐Fluoro‐5’‐norcarbonucleoside Phosphonates as Potent Anti‐HIV Agents

Transgenic Mice, Carrying an Expressed Anti-HIV Ribozyme in Their Genome, Show No Sign of Phenotypic Alterations

Model-based anti-HIV therapy

A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody

Related objects

Reset password